The role of S100B-protein in neonatology, pediatric intensive care, and pediatrics;Neuromonitoring mittels S100B-protein: Stellenwert für die neonatologie, pädiatrische intensivmedizin und pädiatrie

Klinische Padiatrie

Volumn 218, Issue 2, 2006, Pages 49-56

  Meyer, Sascha ^a,d   Gottschling, S ^b   Baghai, A ^a   Polcher, T ^a   Strittmatter, M ^c   Gortner, L ^a  

^a Zentrum für Allgemeine Pädiatrie und Neonatologie   (Germany)

^b Klinik für Pädiatrische Hämatologie und Onkologie   (Germany)

^c Klinik für Neurologie mit Stroke Unit

^d SAARLAND UNIVERSITY   (Germany)

Author keywords

Asphyxia; Brain injury; Children; Neuromonitoring; Outcome; S100b protein

Indexed keywords

BIOCHEMICAL MARKER; PROTEIN S100B;

ASPHYXIA; CEREBROVASCULAR ACCIDENT; CHILD; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; ECHOGRAPHY; ELECTROENCEPHALOGRAPHY; GLASGOW COMA SCALE; HUMAN; INTENSIVE CARE; NEONATOLOGY; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; REVIEW; TRAUMATIC BRAIN INJURY; TREATMENT OUTCOME;

ADOLESCENT; AGE FACTORS; ASPHYXIA NEONATORUM; AUTOANTIGENS; BIOLOGICAL MARKERS; BIRTH INJURIES; BRAIN DISEASES; BRAIN INJURIES; BRAIN ISCHEMIA; CEREBRAL INFARCTION; CEREBROVASCULAR ACCIDENT; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS; FEMALE; GLASGOW COMA SCALE; HEART-LUNG MACHINE; HUMANS; INFANT; INFANT, NEWBORN; INTENSIVE CARE; MALE; MONITORING, PHYSIOLOGIC; NERVE GROWTH FACTORS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; S100 PROTEINS; SENSITIVITY AND SPECIFICITY; SEX FACTORS; TIME FACTORS;

EID: 33644923577     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-836607     Document Type: Review

References (60)

1. Akhtar JI, Spear RM, Senac MO, Peterson BM, Diaz SM. Determination of traumatic brain injury with magnetic resonance imaging and S-100B protein in children, despite normal computed tomography of the brain. Pediatr Crit Care Med 2003; 4: 322-326
2. Anderson RE, Hansson LO, Liska J, Settergren G, Vaage J. The effect of cardiotomy suction on the brain injury marker S100B after cardiopulmonary bypass. Ann Thorac Surg 2000; 69: 847-850
3. Anderson RE, Hansson LO, Nilsson O, Liska J, Settergren G, Vaage J. Increase in serum A1000A1-B and S100BB during cardiac surgery arises from extracerebral sources. Ann Thorac Surg 2001; 71: 1512-1517
4. Beems T, Simons KS, van Geel WJA, de Reus HPM, Vos PE, Verbeck MM. Serum- and CSF-concentrations of brain-specific proteins in hydrocephalus. Acta Neurochir 2003; 145: 37-43
5. Berger R. Biomarkers or neuroimaging in central nervous system injury: Will the real "gold standard" please stand up? Pediatr Crit Care Med 2003; 4: 391
6. Berger RP, Pierce MC, Wisnieski SR, Adelson PD, Kochanek P. Serum S100B concentrations are increased after closed head injury in children: a preliminary study. J Neurotrauma 2002; 19: 1404-1409
7. Berger RP, Pierce MC, Wisniewski SR, Adelson PD, Clark RSB, Ruppel RA, Kochanek PM. Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children. Pediatrics 2002; 109: e31
8. Blennow M, Savman K, Ilves P, Thoresen M, Rosengren L. Brain-specific proteins in the cerebrospinal fluid of severely asphyxiated newborn infants. Acta Paediatr 2001; 90: 1171-1175
9. Buonocore G, Perrone S. Biomarkers of hypoxic brain injury in the neonate. Clin Perinatol 2004; 31: 107-116
10. de Vries J, Thijssen WAM, Snels SEA, Menovsky T, Peer NGM, Lamres KJB. Intraoperative values of S-100 protein, myelin basic protein, lactate, and albumin in the CSF and serum of neurosurgical patients. J Neurol Neurosurg Psychiatry 2001; 71: 671-674
11. Dennery PA. Predicting neonatal brain injury. Are we there yet? Arch Pediatr Adolesc Med 2003; 157: 1151-1152
12. Donato R. S-100 proteins. Cell Calcium 1986; 7: 123-145
13. Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 2001; 33: 637-668
14. Gazzolo D, Michetti F, Bruschettini M, Marchese N, Lituania M, Mangraviti S, Pedrazzi E, Bruschettini P. Pediatric concentrations of S100B protein in blood: Age- and sex-related changes. Clin Chem 2003; 49: 967-970
15. Gazzolo D, Di Iorio R, Marinoni E, Masetti P, Serra G, Giovanni L, Michetti F. S100B protein is increased in asphyxiated term infants developing intraventricular hemorrhage. Crit Care Med 2002; 30: 1356-1360
16. Gazzolo D, Marinoni E, Di Ioria R, Bruschettini M, Kornacka M, Lituania M, Majewska U, Serra G, Michetti F. Urinary S100B protein measurements: A tool for the early identification of hypoxic-ischemic encephalopathy in asphyxiated full-term infants. Crit Care Med 2004; 32: 131-136
17. Gazzolo D, Vinesi P, Bartocci M, Geloso MC, Bonacci W, Serra G, Haglid KG, Michetti F. S100 blood level as early indicators of intraventricular hemorrhage in preterm infants. Correlation with cerebral Doppler velocimetry. J Neurol Sci 1999; 170: 32-35
18. Gazzolo D, Marioni E, Di Iorio R, Lituania M, Bruschettini PL, Michetti F. Circulating S100B protein is increased in intrauterine growth retarded fetuses. Pediatr Res 2002; 51: 215-219
19. Gazzolo D, Bruschettini M, Corvino V, Oliva R, Sarli R, Lituania M, Bruschetini P, Michetti F. S100B protein concentrations in amniotic fluid are correlated with gestational age and with cerebral ultrasound scanning parameters results in healthy fetuses. Clin Chem 2001; 47: 954-956
20. Hermann M, Ehrenreich H. Brain derived proteins as markers of acute stroke: their relation to pathophysiology, outcome prediction and neuroprotective drug monitoring. Restor Neurol Neurosci 2003; 21: 177-190
21. Howard A, Legon S, Spurr NK, Walters JRF. Molecular cloning and chromosome assignment of human calbindin-D9K. Biochem Biophys Res Commun 1992; 185: 663-669
22. Infante JR, Martinez A, Ochoa J, Canadillas F, Torres-Avisbal M, Vallejo JA, Gonzalez FM, Pacheco C, Latre JM. Cerebrospinal fluid S-100 protein levels in neurological pathologies. J Physiol Biochem 2003; 59: 255-261
23. Infante JR, Torres-Avisbal M, Martinez A, Vallejo JA, Aguilera C, Contreras P, Benitez A, Latre JM. Evaluation of tumor marker S-100 in cerebrospinal fluid from subjects with non-ischemic brain pathologies. Tumor Biology 2000; 21: 38-45
24. Ingebrigtsen T, Romner S, Marup-Jensen S, Dons M, Lundquist C, Alling C, Borgesen SE. The clinical value of serum S-100 protein measurements in minor head injury: a Scandinavian multicentre study. Brain Inj 2000; 14: 1047-1055
25. Ingebrigsten T, Waterloo K, Jacobson EA, Langbakk B, Romner B. Traumatic brain damage in minor head injury: relation of serum S-100 protein measurements to magnetic resonance imaging and neurobehavioral outcome. Neurosurgery 1999; 45: 468-475
26. Ingebrigtsen T, Romner B. Biochemical serum markers for brain damage: a short review with emphasis on clinical utility in mild head injury. Restor Neurol Neurosci 2003; 21: 171-176
27. Isobe T, Ishioka N, Okuyama T. The amino-acid sequence of the α subunit in bovine brain S-100 protein. Eur J Biochem 1981; 116: 79-86
28. Isobe T, Okuyama T. Structural relation of two S-100 proteins in bovine brain; subunit composition of S-100-a protein. Eur J Biochem 1981; 115: 469-474
29. Isobe T, Okuyama T. The amino-acid sequence of S-100 protein (PAP I-b) and its relationship to calcium-binding proteins. Eur J Biochem 1978; 89: 379-388
30. Jensen E, Sandstrom K, Andreasson S, Nilsson K, Berggren H, Larsson LE. Increased levels of S-100 protein after cardiac surgery with cardiopulmonary bypass and general surgery in children. Paediatr Anaesth 2000; 10: 297-302
31. Lamers KJ, Vos P, Verbeek MM, Rosmalen F, van Geel WJ, Engelen BG van. Protein S-100B, neuron-specific enolase (NSE), myelin basic protein (MBP) and glial fibrillary acidic protein (GFAP) in cerebrospinal fluid (CSF) and blood of neurological patients. Brain Res Bull 2003; 15: 261-264
32. Lardner D, Davidson A, McKenzie I, Cochrane A. Delayed rise in serum S100B levels and adverse neurological outcome in infants and children undergoing cardiopulmonary bypass. Paediatr Anaesth 2004; 14: 495-500
33. Leviton A, Dammann O. Brain damage markers in children. Neurobiological and clinical aspects. Acta Paediatr 2002; 91: 9-13
34. Marchi N, Rasmussen P, Kapural M, Fazio V, Kight K, Mayberg M, Kanner A, Ayumar B, Albensi B, Cavaglia M, Janigro D. Peripheral markers of brain damage and blood-brain-barrier dysfunction. Restor Neurol Neurosc 2003; 21: 109-121
35. Marks A, Allore RJ. S-100 protein and Down syndrome. Bioessays 1990; 12: 381-383
36. McAdory BS, Eldik LJ Van, Norden JJ. S100B, a neurotrophic protein that modulates neuronal protein phosphorylation, is up-regulated during lesion-induced collateral sprouting and reactive synaptogenesis. Brain Res 1998; 813: 211-217
37. Michetti F, Gazzolo D. S100B protein in biological fluids: A tool for perinatal medicine? Clin Chem 2002; 48: 2097-2014
38. Moore BW. A soluble protein characteristic of the nervous system. Biochem Biophys Res Commun 1965; 19: 739-743
39. Nagdyman N, Grimmer I, Scholz T, Müller M, Obladen M. Predictive value of brain-specific proteins in serum or neurodevelopmental outcome after birth asphyxia. Pediatr Res 2003; 54: 270-275
40. Nagdyman N, Körnen W, KO HK, Müller C, Obladen M. Early biochemical indicators of hypoxic-ischemic encephalopathy after birth asphyxia. Pediatr Res 2001; 49: 502-506
41. Ozatik MA, Tarcan O, Kale A, Askin GA, Balci M, Undar A, Kucukaksu DS, Sener E, Tasdemir O. Do S100beta protein level increases due to inflammation due to cardiopulmonary bypass occur without any neurological deficits? Perfusion 2002; 17: 335-338
42. Park ES, Park CI, Baek SY, Kim SW, Baek SK, Kim HO. Serum immunoreactivity to S-100 in children with cerebral palsy and delayed development and in their healthy parents. Yonsei Med J 2000; 41: 328-332
43. Park ES, Park CI, Choi KS, Choi IH, Shin JS. Over-expression of S100B protein in children with cerebral palsy or delayed development. Brain Dev 2004; 26: 190-196
44. Portela LVC, Tort ABL, Schaf DV, Ribeiro L, Nora DB, Walz R, Rotta LN, Silva CT, Busnello JV, Kapczinski F, Goncalves CA, Souza DO. The serum S100B concentration is age-dependent. Clin Chem 2002; 48: 950-952
45. Romner B, Ingebrigsten T, Kongstad P, Borgesen SE. Traumatic brain damage: serum S-100 protein measurements related to neuroradiological findings. J Neurotrauma 2000; 17: 641-647
46. Schulpis KH, Kariyannis C, Papassotiriou I. Serum levels of neural protein S-100B in phenylketonuria. Clin Biochem 2004; 37: 76-79
47. Shaaban AM, Harmer M, Elliot M, Thomas AL, Kirkham F. A pilot study of evaluation of cerebral function by S100beta protein and near-infrared spectroscopy during cold and warm cardiopulmonary bypass in infants and children undergoing open-heart surgery. Anaesthesia 2004; 59: 20-26
48. Shaaban AM, Harmer M, Vaughan R. Serum S100 protein as a marker of cerebral damage during cardiac surgery. Brit J Anaesth 2000; 85: 287-298
49. Spinella PC, Dominguez T, Drott HE, Huh J, McCormick L, Rajendra A, Argon J, McIntosh T, Helfaer M. S-100beta protein serum levels in healthy children and its association with outcome in pediatric traumatic brain injury. Crit Care Med 2003; 31: 939-945
50. Spinella PC, Donoghue A, Rajendra A, Drott HR, Dominguez TE, Helfaer M. Cerebrospinal fluid levels of S-100beta in children and its elevation in pediatric meningitis. Pediatr Crit Care 2004; 5: 53-57
51. Synder-Ramos SA, Bottiger BW. Molecular markers of brain damage - clinical and ethical implications with particular focus on cardiac arrest. Restor Neurol Neurosci 2003; 21: 123-139
52. Synder-Ramos SA, Gruhlke T, Bauer T, Bauer M, Luntz AP, Motsch J, Martin E, Vahl CF, Missler U, Wiesmann M, Böttiger BW. Cerebral and extracerebral release of protein S100B in cardiac surgical patients. Anaesthesia 2004; 59: 344-349
53. Unertl K, Kottler M. Prognostische Scores in der Intensivmedizin. Anaesthesist 1997; 46: 471-480
54. van Passel R, Schlooz WA, Lamers KJ, Lemmens WA, Rotteveel JJ. S100b protein, glia and Gilles de la Tourette syndrome. Eur J Paediatr Neurol 2001; 5: 15-19
55. Wainwright MS, Craft JM, Griffin WS, Marks A, Pineda J, Padgett K, Eldik J Van. Increased susceptibility of S100B transgenic mice to perinatal hypoxia-ischemia. Ann Neurol 2004; 56: 61-67
56. Whitelaw A, Rosengren L, Blennow M. Brain specific proteins in posthaemorrhagic ventricular dilatation. Arch Dis Child (Fetal and Neonatal Ed) 2001; 84: F90-F91
57. Woertgen C, Rothoerl RD, Holzschuh M Metz C, Brawanski A. Comparison of serial S-100 and NSE serum measurements after severe head injury. Acta Neurochir 1997; 139: 1161-1164
58. Woertgen C, Rothoerl RD, Metz C, Brawanski A. Comparison of clinical, radiologic, and serum marker as prognostic factors after severe head injury. J Trauma 1999; 47: 1126-1130
59. Wunderlich MT, Ebert AD, Kratz T, Goertler M, Jost S, Hermann M. Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage. Stroke 1999; 30: 1190-1195
60. Zimmer DB, Cornwall EH, Landar A, Song W. The S100 protein family: history, function, and expression. Brain Res Bull 1995; 37: 417-429